Cell Source Inc (CLCS)
OTHER OTC:CLCS
US Market
Holding CLCS?
Track your performance easily

Cell Source (CLCS) Income Statement

10 Followers

Cell Source Income Statement

Last quarter (Q ), Cell Source's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Cell Source's net income was $-1.83M. See Cell Source’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 4.34M$ 4.33M$ 4.18M$ 4.02M$ 3.64M$ 3.82M
Operating Income
$ -4.34M$ -4.33M$ -4.18M$ -4.02M$ -3.64M$ -3.82M
Net Non Operating Interest Income Expense
--$ 992.41K$ -380.23K$ -397.73K$ -800.52K
Other Income Expense
$ -16.70K$ -52.82K$ 14.33K$ 665.01K$ 383.63K$ -148.20K
Pretax Income
$ -2.13M$ -2.55M$ -2.18M$ -5.37M$ -4.23M$ -4.47M
Tax Provision
$ -1.48M$ -1.48M$ -754.66K$ -1.77M$ -1.54M-
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -6.45M$ -6.55M$ -6.33M$ -6.45M$ -5.44M$ -3.73M
Basic EPS
$ -0.16$ -0.17$ -0.18$ -0.19$ -0.19-
Diluted EPS
$ -0.16$ -0.17$ -0.18$ -0.19$ -0.19$ -0.18
Basic Average Shares
$ 158.40M$ 37.79M$ 34.84M$ 33.12M$ 29.10M$ 28.33M
Diluted Average Shares
$ 158.40M$ 37.79M$ 34.84M$ 33.12M$ 29.10M$ 28.33M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 4.34M$ 4.33M$ 4.18M$ 4.02M$ 3.64M$ 3.82M
Net Income From Continuing And Discontinued Operation
$ -5.15M$ -5.32M$ -5.17M$ -5.47M$ -4.56M$ -4.47M
Normalized Income
$ -3.11M$ -4.03M-$ -7.14M--
Interest Expense
------
EBIT
$ -8.50M$ -6.80M$ -5.92M$ -4.11M$ -3.62M$ -4.18M
EBITDA
$ -8.50M$ -6.80M$ -5.92M$ -4.11M$ -3.62M$ -4.16M
Currency in USD

Cell Source Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis